Protein-DNA interaction and CpG methylation at rep*/vIL-10p of latent epstein-barr virus genomes in lymphoid cell lines

Biological Chemistry

Volumn 382, Issue 10, 2001, Pages 1411-1419

  Niller, H H ^a   Salamon, D ^a   Takacs, M ^a   Uhlig, J ^a   Wolf, H ^a   Minarovits, J ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Bisulfite sequencing; Dimethyl sulfate; Genomic footprints; Latency; Replication

Indexed keywords

HELICASE; INTERLEUKIN 10;

ARTICLE; B LYMPHOCYTE; CELL LINE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; HUMAN; IN VIVO STUDY; LATENT VIRUS INFECTION; LYMPHOID CELL; METHYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA INTERACTION; VIRUS GENOME; VIRUS REPLICATION;

BASE SEQUENCE; CELL LINE; CPG ISLANDS; DNA; DNA METHYLATION; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; INTERLEUKIN-10; LYMPHOCYTES; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEINS; VIRUS REPLICATION;

EID: 0035159258     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2001.174     Document Type: Article

References (52)

1. Replication of latent Epstein-Barr virus genomes in Raji cells
2. CpG islands as genomic footprints of promoters that are associated with replication origins
3. Specific protection of methylated CpGs in mammalian nuclei
4. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
5. Regulation of E2F: A family of transcription factors involved in proliferation control
6. A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus
7. A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle
8. High sensitivity mapping of methylated cytosines
9. Initiation of DNA replication at CpG islands in mammalian chromosomes
10. Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2)
11. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus
12. A genomic sequencing protocol that yields a positive display of 5-methyl-cytosine residues in individual DNA strands
13. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis
14. Effects of different DNA polymerases in ligation-mediated PCR: Enhanced genomic sequencing and in vivo footprinting
15. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line
16. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication
17. The short unique region of the B95-8 Epstein-Barr virus genome
18. The methylation paradox
19. Gamma ray-induced loss of expression of HLA and glyoxalase 1 alleles in lymphoblastoid cells
20. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promoter usage
21. Epstein-Barr virus and its replication
22. Rep*: A viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus
23. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB virus
24. Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin
25. 5-Azacytidine up-regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line Rael
26. Sequencing end-labeled DNA with base specific chemical cleavages
27. Levels of Epstein-Barr virus DNA in lymphoblastoid cell lines are correlated with frequencies of spontaneous lytic growth but not with levels of expression of EBNA-1, EBNA-2, or latent membrane protein
28. Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA
29. Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas
30. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus
31. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1
32. In vivo footprinting of a muscle-specific enhancer by ligation mediated PCR
33. Automated fluorescent genomic sequencing as applied to the methylation analysis of the human ornithine decarboxylase gene
34. Nucleoprotein complexes and DNA 5′-ends at oriP of Epstein-Barr virus
35. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein
36. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components
37. Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells
38. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes
39. De novo DNA methylation at nonrandom founder sites 5′ from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes
40. Protein-DNA-binding and CpG-methylation at nucleotide resolution of latency associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus
41. Identification of minimal oriP of Epstein-Barr virus required for DNA replication
42. Analysis of methylation patterns in the regulatory region of the latent Epstein-Barr virus promoter BCR2 by automated fluorescent genomic sequencing
43. Epigenetics of latent Epstein-Barr virus genomes: High resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and latent membrane protein 2B genes
44. Transcriptional analysis of the Epstein-Barr virus interleukin-10 homologue during the lytic cycle
45. Novel downstream elements upregulate transcription initiated from an Epstein-Barr virus latent promoter
46. The TRANSFAC system on gene expression regulation
47. Epstein-Barr virus derived plasmids replicate only once per cell cycle and are not amplified after entry into cells
48. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells
49. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
50. The minimal replicator of Epstein-Barr virus oriP
51. Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10
52. Cell cycle regulation of E2F site occupation in vivo